NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 61 filers reported holding NUVALENT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $646,476 | +29.8% | 14,063 | +19.0% | 0.00% | – |
| Q2 2023 | $498,197 | +14.9% | 11,814 | -28.9% | 0.00% | – |
| Q1 2023 | $433,538 | +26.2% | 16,617 | +44.1% | 0.00% | – |
| Q4 2022 | $343,483 | +133.7% | 11,534 | +52.7% | 0.00% | – |
| Q3 2022 | $147,000 | +24.6% | 7,553 | -13.0% | 0.00% | – |
| Q2 2022 | $118,000 | -18.6% | 8,677 | -16.7% | 0.00% | – |
| Q1 2022 | $145,000 | +9.0% | 10,413 | +49.4% | 0.00% | – |
| Q4 2021 | $133,000 | -10.7% | 6,970 | +5.3% | 0.00% | – |
| Q3 2021 | $149,000 | – | 6,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,788,981 | $83,055,854 | 13.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $595,332,695 | 12.32% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $106,531 | 11.90% |
| COMMODORE CAPITAL LP | 913,621 | $27,208 | 4.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 302,963 | $9,022,238 | 2.58% |
| Boxer Capital, LLC | 1,210,192 | $36,039,518 | 1.90% |
| Perceptive Advisors | 2,255,007 | $67,154,108 | 1.89% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,673,214 | $49,828,313 | 0.74% |
| Avoro Capital Advisors LLC | 1,555,555 | $46,324,428 | 0.69% |
| AlphaCentric Advisors LLC | 15,500 | $461,590 | 0.46% |